Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1698077 |
394 | 3 | CARDIOTOXICITY//ANTHRACYCLINES//SHIKONIN | 32432 |
846 | 2 | CARDIOTOXICITY//ANTHRACYCLINES//DOXORUBICIN | 11845 |
21165 | 1 | AN 9//METHOXYMORPHOLINO DOXORUBICIN//AD 198 | 453 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | AN 9 | authKW | 579768 | 2% | 83% | 10 |
2 | METHOXYMORPHOLINO DOXORUBICIN | authKW | 417435 | 1% | 100% | 6 |
3 | AD 198 | authKW | 404781 | 2% | 73% | 8 |
4 | SABARUBICIN | authKW | 378781 | 2% | 78% | 7 |
5 | AN 7 | authKW | 289884 | 1% | 83% | 5 |
6 | BARMINOMYCIN | authKW | 278290 | 1% | 100% | 4 |
7 | HL60 HUMAN PROMYELOCYTIC LEUKAEMIA | authKW | 248471 | 1% | 71% | 5 |
8 | BUTYRIC ACID PRODRUG | authKW | 208718 | 1% | 100% | 3 |
9 | DOXOFORM | authKW | 208718 | 1% | 100% | 3 |
10 | MORPHOLINYLANTHRACYCLINES | authKW | 208718 | 1% | 100% | 3 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 2806 | 41% | 0% | 187 |
2 | Chemistry, Medicinal | 988 | 14% | 0% | 65 |
3 | Pharmacology & Pharmacy | 986 | 28% | 0% | 129 |
4 | Biochemistry & Molecular Biology | 106 | 17% | 0% | 76 |
5 | Toxicology | 52 | 4% | 0% | 18 |
6 | Chemistry, Organic | 25 | 5% | 0% | 23 |
7 | Biophysics | 16 | 3% | 0% | 15 |
8 | Biotechnology & Applied Microbiology | 15 | 4% | 0% | 18 |
9 | CYTOLOGY & HISTOLOGY | 7 | 0% | 0% | 1 |
10 | Chemistry, Multidisciplinary | 2 | 5% | 0% | 22 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ONCOL CHEM CORE TECHNOL | 139145 | 0% | 100% | 2 |
2 | PHARMACOL EXPT ONCOL | 139141 | 1% | 50% | 4 |
3 | FELSENSTEIN MED | 133168 | 8% | 5% | 38 |
4 | AEG CREA | 69573 | 0% | 100% | 1 |
5 | CELLULAIRE MOL PHARMACOL | 69573 | 0% | 100% | 1 |
6 | CLIN STUDY ANTICANCER MOL TARGETED DRUGS | 69573 | 0% | 100% | 1 |
7 | DAVIDOV CANC | 69573 | 0% | 100% | 1 |
8 | GRP MENARINI | 69573 | 0% | 100% | 1 |
9 | HIGH MOL WEIGHT COMPOUNDS | 69573 | 0% | 100% | 1 |
10 | LCCC ANIM STUDIES CORE IL | 69573 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 7257 | 6% | 0% | 28 |
2 | CANADIAN JOURNAL OF MEDICAL TECHNOLOGY | 4346 | 0% | 6% | 1 |
3 | JOURNAL OF MEDICINAL CHEMISTRY | 4337 | 8% | 0% | 37 |
4 | ANTI-CANCER DRUGS | 2502 | 2% | 0% | 11 |
5 | CANCER RESEARCH | 2133 | 8% | 0% | 35 |
6 | ONCOLOGY RESEARCH | 1928 | 1% | 0% | 6 |
7 | BIOCHEMICAL PHARMACOLOGY | 1781 | 5% | 0% | 22 |
8 | INVESTIGATIONAL NEW DRUGS | 1704 | 2% | 0% | 8 |
9 | BIOPHARM-THE TECHNOLOGY & BUSINESS OF BIOPHARMACEUTICALS | 694 | 0% | 1% | 1 |
10 | CANCER COMMUNICATIONS | 680 | 0% | 1% | 1 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AN 9 | 579768 | 2% | 83% | 10 | Search AN+9 | Search AN+9 |
2 | METHOXYMORPHOLINO DOXORUBICIN | 417435 | 1% | 100% | 6 | Search METHOXYMORPHOLINO+DOXORUBICIN | Search METHOXYMORPHOLINO+DOXORUBICIN |
3 | AD 198 | 404781 | 2% | 73% | 8 | Search AD+198 | Search AD+198 |
4 | SABARUBICIN | 378781 | 2% | 78% | 7 | Search SABARUBICIN | Search SABARUBICIN |
5 | AN 7 | 289884 | 1% | 83% | 5 | Search AN+7 | Search AN+7 |
6 | BARMINOMYCIN | 278290 | 1% | 100% | 4 | Search BARMINOMYCIN | Search BARMINOMYCIN |
7 | HL60 HUMAN PROMYELOCYTIC LEUKAEMIA | 248471 | 1% | 71% | 5 | Search HL60+HUMAN+PROMYELOCYTIC+LEUKAEMIA | Search HL60+HUMAN+PROMYELOCYTIC+LEUKAEMIA |
8 | BUTYRIC ACID PRODRUG | 208718 | 1% | 100% | 3 | Search BUTYRIC+ACID+PRODRUG | Search BUTYRIC+ACID+PRODRUG |
9 | DOXOFORM | 208718 | 1% | 100% | 3 | Search DOXOFORM | Search DOXOFORM |
10 | MORPHOLINYLANTHRACYCLINES | 208718 | 1% | 100% | 3 | Search MORPHOLINYLANTHRACYCLINES | Search MORPHOLINYLANTHRACYCLINES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |